APA (7th ed.) Citation

Naidoo A, Naidoo K, Ramsuran V, Reddy M, & Padayatchi N. (2017). Hyperbilirubinemia in atazanavir-treated human immunodeficiency virus-infected patients: The impact of the UGT1A1*28 allele. Dove Medical Press.

Chicago Style (17th ed.) Citation

Naidoo A, Naidoo K, Ramsuran V, Reddy M, and Padayatchi N. Hyperbilirubinemia in Atazanavir-treated Human Immunodeficiency Virus-infected Patients: The Impact of the UGT1A1*28 Allele. Dove Medical Press, 2017.

MLA (9th ed.) Citation

Naidoo A, et al. Hyperbilirubinemia in Atazanavir-treated Human Immunodeficiency Virus-infected Patients: The Impact of the UGT1A1*28 Allele. Dove Medical Press, 2017.